Clinical Intervention Psychosis and Addiction (KLIPS)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified February 2011 by University of Cologne.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
University of Cologne
ClinicalTrials.gov Identifier:
NCT01411566
First received: March 2, 2011
Last updated: August 5, 2011
Last verified: February 2011

March 2, 2011
August 5, 2011
January 2011
November 2011   (final data collection date for primary outcome measure)
  • Substance use [ Time Frame: one year ] [ Designated as safety issue: No ]
  • Substance use [ Time Frame: 3 months ] [ Designated as safety issue: No ]
  • Substance use [ Time Frame: 6 months ] [ Designated as safety issue: No ]
  • Change in drug use motivation [ Time Frame: 3 months ] [ Designated as safety issue: No ]
  • Change in drug use motivation [ Time Frame: 6 months ] [ Designated as safety issue: No ]
  • Change in drug use motivation [ Time Frame: 1 year ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT01411566 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Clinical Intervention Psychosis and Addiction
Evaluation of an Integrative Therapeutic Concept for Schizophrenic Patients With Comorbid Substance Use Disorder

The purpose of this study is to evaluate an integrative therapeutic concept for schizophrenic patients with comorbid substance use disorder.

Not Provided
Interventional
Phase 0
Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double Blind (Subject, Investigator, Outcomes Assessor)
Primary Purpose: Treatment
  • Psychosis
  • Substance Abuse
  • Behavioral: Skills trainig for patients with dual diagnosis
    Skills trainig for patients with dual diagnosis
  • Behavioral: regular treatment
    regular treatment
  • Experimental: Treatment
    Intervention: Behavioral: Skills trainig for patients with dual diagnosis
  • Active Comparator: Control
    Intervention: Behavioral: regular treatment
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
122
December 2011
November 2011   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Schizophrenia
  • Addiction
  • Written statement of agreement
  • Majority

Exclusion Criteria:

  • Acute psychosis
  • Further neuropsychiatric disorder
Both
18 Years to 60 Years
No
Germany
 
NCT01411566
Koeln-Fortune 104/2010
No
Dr. Joerg Daumann, PhD, University of Cologne
University of Cologne
Not Provided
Study Chair: Joerg Daumann, PhD University of Cologne
University of Cologne
February 2011

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP